title: Very late bioresorbable vascular scaffold thrombosis: a new clinical entity.
authors.affiliation: Department of Medicine, Montreal Heart Institute, University of Montreal, Montreal, QC, Canada.
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Azzalini
authors.forename: Malek
authors.initials: M
authors.lastname: Al-Hawwas
authors.forename: Philippe L
authors.initials: PL
authors.lastname: L'Allier
mesh_terms: D020341:Absorbable Implants; D000369:Aged, 80 and over; D056988:Anterior Wall Myocardial Infarction / Q000175:diagnosis / Q000209:etiology; D001918:Brachytherapy; D000077144:Clopidogrel; D017023:Coronary Angiography; D023903:Coronary Restenosis / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D023921:Coronary Stenosis / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D003328:Coronary Thrombosis / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D054855:Drug-Eluting Stents; D005260:Female; D006801:Humans; D008670:Metals; D009203:Myocardial Infarction / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D062645:Percutaneous Coronary Intervention / Q000009:adverse effects / Q000295:instrumentation*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage; D011474:Prosthesis Design; D012720:Severity of Illness Index; D015607:Stents; D013988:Ticlopidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D013997:Time Factors; D041623:Tomography, Optical Coherence; D016896:Treatment Outcome
chemical_list: D008670:Metals; D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine